Innovation for Life®

Elixir Medical is committed to transforming care for patients with heart and vascular disease through innovation.

Innovation in the DynamX Medical Device for Vascular Disease


Learn more about the DynamX Coronary Bioadaptor System, the first implant for coronary artery disease that adapts to vessel physiology.

Clinical Evidence on International Homepage


See DynamX data demonstrating positive adaptive remodeling, restoration of vessel function and return towards baseline angulation.

Elixir Medical Corporation News on International Homepage


Saving lives and helping patients enjoy daily life is what drives us every day. Read about developments with Elixir Medical and its products.

Elixir About Us Link on International Homepage


Elixir Medical is committed to transforming care of patients with heart and vascular disease through innovation. Learn more about Elixir Medical.

PMN 567 Rev C

Corporate Headquarters
920 N. McCarthy Blvd.
Milpitas, CA 95035 U.S.

Elixir, Innovation for Life and DESyne are registered trademarks, and DynamX a trademark, in the US and internationally for Elixir Medical Corporation.
DynamX Coronary Bioadaptor System and DESyne X2 Novolimus Eluting Coronary Stent System are CE Mark approved.
©2020 Elixir Medical. All rights reserved.
International (OUS) Use Only. DynamX and DESyne X2 are intended to improve coronary luminal diameter in patients with symptomatic ischemic heart disease due to discrete de novo native coronary artery lesions. CAUTION: The law restricts these devices to sale by or on the order of a physician. Indications, contraindications, warnings and instructions for use can be found in the product labeling supplied with each device.

Sign up to receive news and information about Elixir Medical, our products and other relevant information as it becomes available.

Site designed by The Deciding Factor, Inc.